Revance Replaces Lidocaine with Mepivacaine in RHA Filler Line
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
Clinical trial results showed improvements in neck appearance lasting up to six months following treatment.